These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 9815803)

  • 41. Molecular analysis of the putative tumour-suppressor gene EXTL1 in neuroblastoma patients and cell lines.
    Mathysen D; Van Roy N; Van Hul W; Laureys G; Ambros P; Speleman F; Wuyts W
    Eur J Cancer; 2004 May; 40(8):1255-61. PubMed ID: 15110891
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deletion mapping of chromosomal region 1p32-pter in primary breast cancer.
    Bièche I; Khodja A; Lidereau R
    Genes Chromosomes Cancer; 1999 Mar; 24(3):255-63. PubMed ID: 10451706
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study.
    Cohn SL; Look AT; Joshi VV; Holbrook T; Salwen H; Chagnovich D; Chesler L; Rowe ST; Valentine MB; Komuro H
    Cancer Res; 1995 Feb; 55(4):721-6. PubMed ID: 7850780
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlation between genetic alteration and long-term clinical outcome of patients with oligodendroglial tumors, with identification of a consistent region of deletion on chromosome arm 1p.
    Hashimoto N; Murakami M; Takahashi Y; Fujimoto M; Inazawa J; Mineura K
    Cancer; 2003 May; 97(9):2254-61. PubMed ID: 12712480
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of a consistent region of allelic loss on 1p32 in meningiomas: correlation with increased morbidity.
    Sulman EP; Dumanski JP; White PS; Zhao H; Maris JM; Mathiesen T; Bruder C; Cnaan A; Brodeur GM
    Cancer Res; 1998 Aug; 58(15):3226-30. PubMed ID: 9699646
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival.
    Ragnarsson G; Eiriksdottir G; Johannsdottir JT; Jonasson JG; Egilsson V; Ingvarsson S
    Br J Cancer; 1999 Mar; 79(9-10):1468-74. PubMed ID: 10188892
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic significance of DNA di-tetraploidy in neuroblastoma.
    Ladenstein R; Ambros IM; Pötschger U; Amann G; Urban C; Fink FM; Schmitt K; Jones R; Slociak M; Schilling F; Ritter J; Berthold F; Gadner H; Ambros PF
    Med Pediatr Oncol; 2001 Jan; 36(1):83-92. PubMed ID: 11464912
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection and cloning of a common region of loss of heterozygosity at chromosome 1p in breast cancer.
    Nagai H; Negrini M; Carter SL; Gillum DR; Rosenberg AL; Schwartz GF; Croce CM
    Cancer Res; 1995 Apr; 55(8):1752-7. PubMed ID: 7712484
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuroblastoma: clinical significance of genetic abnormalities.
    Brodeur GM
    Cancer Surv; 1990; 9(4):673-88. PubMed ID: 2101728
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number.
    Wang Q; Diskin S; Rappaport E; Attiyeh E; Mosse Y; Shue D; Seiser E; Jagannathan J; Shusterman S; Bansal M; Khazi D; Winter C; Okawa E; Grant G; Cnaan A; Zhao H; Cheung NK; Gerald W; London W; Matthay KK; Brodeur GM; Maris JM
    Cancer Res; 2006 Jun; 66(12):6050-62. PubMed ID: 16778177
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Demonstration of two regions involved in chromosome 1p deletion in breast tumors].
    Bièche I; Champème MH; Matifas F; Cropp C; Callahan R; Lidereau R
    Bull Cancer; 1994 Feb; 81(2):108-13. PubMed ID: 7894115
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma.
    White PS; Thompson PM; Gotoh T; Okawa ER; Igarashi J; Kok M; Winter C; Gregory SG; Hogarty MD; Maris JM; Brodeur GM
    Oncogene; 2005 Apr; 24(16):2684-94. PubMed ID: 15829979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peculiar allelotype associated with susceptibility to neuroblastoma.
    Perri P; Pession A; Mazzocco K; Strigini P; Iolascon A; Basso G; Tonini GP
    Genes Chromosomes Cancer; 1996 Sep; 17(1):60-3. PubMed ID: 8889508
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1p.
    Mora J; Cheung NK; Kushner BH; LaQuaglia MP; Kramer K; Fazzari M; Heller G; Chen L; Gerald WL
    J Mol Diagn; 2000 Feb; 2(1):37-46. PubMed ID: 11272900
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detailed deletion mapping of chromosome band 14q32 in human neuroblastoma defines a 1.1-Mb region of common allelic loss.
    Hoshi M; Otagiri N; Shiwaku HO; Asakawa S; Shimizu N; Kaneko Y; Ohi R; Hayashi Y; Horii A
    Br J Cancer; 2000 Jun; 82(11):1801-7. PubMed ID: 10839294
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gene expression profiling of 1p35-36 genes in neuroblastoma.
    Janoueix-Lerosey I; Novikov E; Monteiro M; Gruel N; Schleiermacher G; Loriod B; Nguyen C; Delattre O
    Oncogene; 2004 Aug; 23(35):5912-22. PubMed ID: 15195138
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Loss of heterozygosity and microsatellite instability on chromosome arm 10q in neuroblastoma.
    Lázcoz P; Muñoz J; Nistal M; Pestaña A; Encío IJ; Castresana JS
    Cancer Genet Cytogenet; 2007 Apr; 174(1):1-8. PubMed ID: 17350460
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Frequent loss of heterozygosity on chromosome 14q in neuroblastoma.
    Suzuki T; Yokota J; Mugishima H; Okabe I; Ookuni M; Sugimura T; Terada M
    Cancer Res; 1989 Mar; 49(5):1095-8. PubMed ID: 2563671
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The neuroblastoma, "enfant terrible" among pediatric tumors].
    Laureys G
    Verh K Acad Geneeskd Belg; 2003; 65(1):5-23; discussion 23-8. PubMed ID: 12802894
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A tumor suppressor gene on chromosome 1p32-pter controls the amplification of MYC family genes in breast cancer.
    Bièche I; Champème MH; Lidereau R
    Cancer Res; 1994 Aug; 54(16):4274-6. PubMed ID: 7913873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.